Polθ-IN-1-d3
Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670) [1].
Product Specifications
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
[2H]C([2H])([2H])N(C1=C(C=C(C(Cl)=C1)F)F)C([C@H]2N(C3=CC(C(F)(F)F)=CC(C)=N3)C([C@H]([C@H]2O)O)=O)=O
Molecular Formula
C19H12D3ClF5N3O4
Molecular Weight
482.80
References & Citations
[1]DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER. Patent WO2021028670.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139593S/
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
CAS Number
[2598122-35-9]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7155129 Inquire
Rabbit anti-Zymomonas mobilis subsp. mobilis (strain 31821/ZM4/CP4) ZMO1243 Polyclonal Antibody
Ask
View Details 